Development And Initial Validation Of The Female Assessment Of Male Erectile Dysfunction Detection Scale (Fame): Report Of A Pilot Study

Dr. Eusebio Rubio-Aurioles

Objectives: Erectile dysfunction (ED) is a prevalent condition that can have a significant negative impact on men’s quality of life and also that of their female partners. The objective of this study was to develop a scale for the detection of ED, as assessed by the woman partner. Design and Methods: Qualitative research was conducted via focus groups involving women whose male partners suffer from ED to identify themes/clues. Item construction based on the sexual health inventory for men (SHIM) and qualitative results was subsequently tested using a panel of experts and a panel of women with partners with ED, to document face validity. Concurrent validity analysis was carried out with Spearman’s rho between FAME and clinical diagnosis, SHIM scores, and erectile function domain of the International Index of Erectile Function (IIEF-EF), in a group of 83 couples. Reliability was tested with Cronbach’s alpha, and sensitivity and specificity were checked against clinical diagnosis. Results: Qualitative analysis yielded 44 clues. Following item construction, 23 items were selected. Of these, 21 items demonstrated statistical significance as the best discriminating items using a t-test for independent samples. A final scale of 6 items was then tested for validity and reliability. FAME correlated significantly with clinical diagnosis (0.743, p<0.001), SHIM score (0.829, p<0.001), and IIEF-EF domain (0.684, p<0.001). Cronbach’s alpha was 0.941. Sensitivity was 97.3% and specificity was 68.9%, compared with SHIM’s values of 100.0% and 55.6%. Conclusion: Accurate detection of ED in males by the woman partner is possible. In this study, FAME (completed by the woman) had higher specificity than the SHIM (completed by the man), and demonstrated validity, reliability and sensitivity in this population. Further research is needed to assess the validity of this tool in other populations.


Conflict of Interest: None disclosed
Financial Support/Funding: None disclosed
Recorded: Sydney, Australia, April 2007

Eusebio Rubio-Aurioles
Eusebio Rubio-Aurioles
 more about this speaker
 other talks by the speaker


Dr. Eusebio Rubio-Aurioles

EUSEBIO RUBIO-AURIOLES, M.D., Ph.D. obtained his M.D. at Universidad La Salle in Mexico City (1978) México D.F., and his Ph.D. in the Program of Human Sexuality at New York University. (1988) He completed the post-doctoral training course in sex therapy at the Department of Psychiatry of the Mount Sinai Hospital of New York City (1983).Since 1984 he is professor at the Departamento de Psiquiatría y Salud Mental de la Facultad de Medicina de la Universidad Nacional Autónoma de México.In 1987 he founded the Asociación Mexicana para la Salud Sexual, A.C. where he is the director. Since 1993 has completed 22 clinical trials for the development of drugs for the treatment of sexual dysfunction in males and females. He has published several articles in national and international journals and books, he was the Editor of the Antología de la Sexualidad Humana published by the Consejo Nacional de Población. From 1995 to 1998 he served as the first president of the Federación Mexicana de Educación Sexual y Sexología, A.C. He is currently the President of the World Association for Sexual Health (formerly World Association for Sexology)

Email
Password